Humana Inc (HUM)

Industry Healthcare Plans
This stock can be held in an Investment ISA and an Investment Account
Sell

$231.01

Buy

$231.21

arrow-up$2.20 (+0.96%)

Humana Inc is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group and Healthcare Services.
Prices updated at 14 May 2025, 20:27 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.04%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Healthcare Plans
Chairman
Mr. Kurt J. Hilzinger
CEO
Mr. James A. Rechtin
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
65,680
Head office
500 West Main Street
Louisville
United States
40202
mobile
+1 502 580-1000
letter
lstamper@humana.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Gordon A. Smith
Independent Director
0.13m--0.33m-
Mr. Kurt J. Hilzinger
Chairman of the Board
0.37m--0.61m-
Ms. Karen W. Katz
Independent Director
0.15m--0.39m-
Mr. Frank A. D'Amelio
Independent Director
0.15m--0.37m-
Dr. David T. Feinberg, M.D.,PhD
Independent Director
0.14m--0.34m-
Mr. Jorge S. Mesquita
Independent Director
0.13m--0.37m-
Mr. John W. Garratt
Independent Director
0.14m--0.34m-
Ms. Marcy S. Klevorn
Independent Director
0.14m--0.36m-
Mr. Vishal Agrawal
Chief Strategy and Corporate Development Officer
-----
Mr. Joseph C. Ventura
Chief Legal Officer
-----
Ms. Michelle A. O’Hara
Chief Human Resources Officer
-----
Dr. Wayne A.I. Frederick, M.D.
Independent Director
0.15m--0.39m-
Dr. Raquel C. Bono, M.D.
Independent Director
0.13m--0.33m-
Ms. Celeste M. Mellet
Chief Financial Officer
-----
Mr. John-Paul W. Felter
Senior Vice President, Chief Accounting Officer and Controller
-----
Mr. George Renaudin, II
President, Insurance
0.72m--6.15m-
Dr. Sanjay K. Shetty, M.D.
President, CenterWell
0.69m0.55m-6.44m-
Mr. James A. Rechtin
Director, President and Chief Executive Officer
1.11m--15.58m-
Mr. David E. Dintenfass
President, Enterprise Growth
0.61m5.68m-18.06m-
Mr. Japan A. Mehta
Chief Information Officer
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc13,972,8720.0668411436628.91451630 Apr 202511.58
BlackRock Inc11,689,8630.060013762903.32600530 Apr 20259.69
Dodge & Cox10,198,0401.505675264045106.68930630 Apr 20258.45
Dodge & Cox Stock Fund7,180,5001.676423573005.23654630 Apr 20255.95
State Street Corp5,278,2620.05301-79158-1.4775430 Apr 20254.37

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
02 Jan 2025-Mr. Brad D. Smith--1,169--
31 Dec 2024-Mr. Brad D. Smith254.9358,889771--
31 Dec 2024-Mr. Brad D. Smith254.934,33420--
31 Dec 2024-Mr. Kurt J. Hilzinger254.93171,56814,300--
31 Dec 2024-Mr. Kurt J. Hilzinger254.93144,0352,753--
02 Jan 2025-Mr. Kurt J. Hilzinger--24,034--
31 Dec 2024-Ms. Karen W. Katz254.939,68775--
02 Jan 2025-Ms. Karen W. Katz--2,861--
31 Dec 2024-Dr. David T. Feinberg, M.D.,PhD254.9333,396427--
31 Dec 2024-Dr. David T. Feinberg, M.D.,PhD254.933,56917--
02 Jan 2025-Dr. David T. Feinberg, M.D.,PhD--1,593--
31 Dec 2024-Mr. Timothy S. Huval--7,111--
31 Dec 2024-Mr. Timothy S. Huval256.26948,9258,181--
31 Dec 2024-Ms. Marcy S. Klevorn254.934,33425--
02 Jan 2025-Ms. Marcy S. Klevorn--2,005--
31 Dec 2024-Ms. Susan M. Diamond260.73261332--
31 Dec 2024-Dr. Wayne A.I. Frederick, M.D.254.935,86338--
02 Jan 2025-Dr. Wayne A.I. Frederick, M.D.--2,408--
31 Dec 2024-Dr. Raquel C. Bono, M.D.254.935,86338--
02 Jan 2025-Dr. Raquel C. Bono, M.D.--2,408--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.